Apart from acetylation, several histone methylation marks were also found to be elevated in AD patients, suggesting that the expression of histone methyltransferase (KMT2C, KMT2D, SETD1A, and SETD1B) was also altered [155,168,169]. This evidence concerns the gene PRDM9 and Alzheimer disease.